Canlyniadau Chwilio - Cihan Erol

Prognostic Significance of ARID1A, PTEN and PD-L1 Expressions and MMR Status in Colorectal Cancer Tissue gan Seda KAHRAMAN, Sema Nur ÖZSAN ÇELEBİ, Ayça Dilşad KURATMER, İrfan KARAHAN, Didem Şener DEDE, Mehmet Ali Nahit ŞENDUR, Muhammed Bülent AKINCI, Cihan EROL, Mutlu HIZAL, Burak BİLGİN, Yakup ERGÜN, Fahriye Tuba KÖŞ, Hayriye Tatlı DOĞAN, Bülent YALÇIN

Cael y testun llawn

Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study gan Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos, Mehmet Ali Nahit Sendur, Yunus Emre Altıntas, Tugba Tuylu, Sedat Yildirim, Sedat Biter, Mehmet Mutlu Kıdı, Ertugrul Bayram, Nargiz Majidova, Ibrahim Vedat Bayoglu, Mehmetcan Atak, Kadriye Baskurt, Sinem Akbas, Ali Alkan, Ayberk Bayramgil, Ferit Aslan, Elif Sahin, Onur Yazdan Balcik, Ahmet Ziya Bayhan, Seray Saray, Erkan Arpaci, Yakup Ergun

Cael y testun llawn

Multilocus inherited neoplasia allele syndrome (MINAS) in a Turkish cohort: molecular insights and clinical relevance for precision oncology gan Taha Bahsi, Taha Bahsi, Taha Bahsi, Serhat Seyhan, Serhat Seyhan, Serhat Seyhan, Kaan Helvaci, Umut Demirci, Irem Bilgetekin, Selami Bayram, Mehmet Akif Ozturk, Fatih Aydogan, Serkan Keskin, Kezban Pilanci, Nur Sener, Murat Tatlı, Hakan Harputluoglu, Esat Namal, Aysegul Kargi, Mukremin Uysal, Mahmut Ilhan, Cihan Erol, Naziyet Kose, Kerem Okutur, Halit Karaca, Erkan Dogan, Veli Berk, Ahmet Siyar Ekinci, Mustafa Ozdogan, Mustafa Ozdogan

Cael y testun llawn

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer gan Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu

Cael y testun llawn

Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program gan Mehmet Ali Nahit Sendur, Mutlu Hizal, Burcu Çakar, Oktay Halit Aktepe, Emrah Eraslan, Zafer Arık, İsmail Erturk, Sercan Aksoy, Semra Paydaş, Serkan Değirmencioğlu, Cihan Erol, Necla Demir, Gülcan Bulut, Naziye Ak, Metin Özkan, Alper Sevinç, Nuriye Özdemir, Umut Dişel, Deniz Tural, Mehmet Artaç, Hacı Mehmet Türk, Serkan Menekşe, Sema Sezgin Göksu, Fatih Köse, Cağlayan Geredeli, Meral Günaldı, Başak Oyan Uluç, Fatma Şen, Kerem Oruç, Ömer Fatih Ölmez, Abdullah Sakin, Umut Demirci, Dilek Erdem, Ferhat Ekinci, Nihat Ökten, Leyla Özer, Kerem Okutur, Atakan Demir, Nuri Karadurmuş, Muhammed Bülent Akıncı, Bülent Yalçın, Erhan Gökmen

Cael y testun llawn

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases gan Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur

Cael y testun llawn

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study gan Taha Koray Sahin, Fatih Kemik, Harun Muglu, Bedriye Acikgöz Yildiz, Sedat Biter, Salih Tunbekici, Ahmet Oruc, Ali Kaan Guren, Kerim Kaban, Halil Goksel Guzel, Cihan Erol, Musa Baris Aykan, Bahadir Koylu, Omer Burak Ekinci, Ilknur Deliktas Onur, Ali Kalem, Oguz Altunok, Mustafa Seyyar, Bunyamin Guney, Orhun Akdogan, Rashad Ismayilov, Fadime Sinem Ardic, Melike Yazici, Nargiz Majidova, Sema Turker, Ece Esin, Devrim Cabuk, Hatime Arzu Yasar, Arzu Oguz, Ozan Yazici, Riza Umar Gursu, Mesut Yılmaz, Havva Yesil Cinkir, Ozturk Ates, Emir Celik, Nuri Karadurmus, Umut Demirci, Banu Ozturk, Nil Molinas Mandel, Ibrahim Vedat Bayoglu, Murat Araz, Erdem Goker, Ertugrul Bayram, Dilek Erdem, Fatih Selcukbiricik, Gul Basaran, Ahmet Sezer, Gamze Gokoz Dogu, Yasemin Kemal, Ahmet Bilici, Seyda Gunduz, Deniz Can Guven, Sercan Aksoy

Cael y testun llawn